You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

83 search results for: mechanism of disease

The Role <b>of</b> Type 2 Inflammation in Multiple <b>Disease</b> Trajectories
Infographic

The Role of Type 2 Inflammation in Multiple Disease Trajectories

Dermatology
How type 2 inflammation drives atopic dermatitis and underlies other atopic diseases across multiple disease trajectories including the atopic march.
View more
The Burden <b>of</b> Atopic Dermatitis in Children – Identifying Persistent <b>Disease</b>
expert video

The Burden of Atopic Dermatitis in Children – Identifying Persistent Disease

Dermatology
Dr. Mark Koh explains how to identify children with persistent disease.
View more
The Burden <b>of</b> Atopic Dermatitis in Children – Skin Infections and More Severe <b>Disease</b>
expert video

The Burden of Atopic Dermatitis in Children – Skin Infections and More Severe Disease

Dermatology
Dr. Mark Koh talks about skin infections and their impact on disease severity.
View more
Differences in Manifestations <b>of</b> Type 2 Inflammatory <b>Disease</b>s
expert video

Differences in Manifestations of Type 2 Inflammatory Diseases

Dermatology
Dr. Brian Kim highlights the differences in manifestation of type 2 inflammatory diseases.
View more
AD, PN, and CSU: Distinct, Pruritic <b>Disease</b>s
expert video

AD, PN, and CSU: Distinct, Pruritic Diseases

Dermatology
Dr. Elmariah explains how AD, PN, and CSU are distinct diseases with the common, burdensome symptom of itch.
View more
Impact <b>of</b> Advanced Systemic Therapies on <b>Disease</b> Control in AD
expert video

Impact of Advanced Systemic Therapies on Disease Control in AD

Dermatology
Dr. Simpson discusses impact of advanced systemic therapies in AD, and the link between inhibition of type 2 inflammation and reduced IgE levels.
View more
How do You Define Active <b>Disease</b> (CRSwNP) When Looking at the Nose With an Endoscope?
expert video

How do You Define Active Disease (CRSwNP) When Looking at the Nose With an Endoscope?

Rhinology
In this video clip from the EAACI 2024 symposium, Dr. Mullol discusses the challenge of defining active nasal disease using an endoscope.
View more
Atopic Dermatitis (AD) is a Type 2 Inflammatory <b>Disease</b>
videoanimation

Atopic Dermatitis (AD) is a Type 2 Inflammatory Disease

Dermatology
Discover the pathophysiological mechanisms involved in atopic dermatitis.
View more
Neuroimmune Axis in Atopic Dermatitis
expert video

Neuroimmune Axis in Atopic Dermatitis

Dermatology
A review of the neuroimmune mechanisms and changes to skin barrier that result in itch in AD.
View more
Neuroimmune Axis and Neuroinflammation in PN
expert video

Neuroimmune Axis and Neuroinflammation in PN

Dermatology
A review of the neuroimmune mechanisms and changes to the dermis that result in itch in PN.
View more
Mast Cells and the Neuroimmune Axis in CSU
expert video

Mast Cells and the Neuroimmune Axis in CSU

Dermatology
A review of the neuroimmune mechanisms and activation of mast cells that result in itch in CSU.
View more
Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​
expert video

Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​

Dermatology
A review of the shared and unique neuroimmune mechanisms in the generation of itch across AD, PN, and CSU.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: FranceChange country/region